CENESTIN Side Effects

6139577-7 | Calcinosis, Rash
on Mar 23, 2009 Female patient from UNITED STATES , 66 years of age, weighting 130.0 lb, was diagnosed with amnesia, hysterectomy (What is hysterectomy?) and was treated with Cenestin (View Usage). Patient experienced the following unwanted or unexpected effects: calcinosis, rash (What is rash?). Cenestin dosage: 1 Tablet (1 In 1 D), Oral. During the same period patient was treated with FOSAMAX (View Fosamax Review and Fosamax Label ).

5845127-2 | Diarrhoea, Stomach Discomfort
Patient was taking Cenestin (View Usage). Patient had the following side effects: diarrhoea, stomach discomfort on Aug 13, 2008 from UNITED STATES Additional patient health information: Female patient , 38 years of age, weighting 135.0 lb, was diagnosed with artificial menopause and. Cenestin dosage: 1 Pill Per Day.

5736976-X | Abdominal Distension, Abdominal Pain, Bone Pain, Gastric Disorder, Headache, Hypoaesthesia, Insomnia, Memory Impairment, Nervous System Disorder
Adverse event was reported on May 12, 2008 by a Female patient taking Cenestin (View Usage) (Dosage: 0.625 1 Once A Day Mouth) was diagnosed with hysterectomy (What is hysterectomy?) and. Location: UNITED STATES , weighting 121.0 lb, After Cenestin was administered, patient had the following side effects: abdominal distension, abdominal pain (What is abdominal pain?), bone pain, gastric disorder, headache (What is headache?), hypoaesthesia, insomnia, memory impairment, nervous system disorder.

5429183-1 | Haemangioma, Muscle Spasms, Myalgia
on Aug 20, 2007 Female patient from UNITED STATES , 42 years of age, was treated with Cenestin (View Usage). Patient experienced the following unwanted or unexpected effects: haemangioma, muscle spasms, myalgia. Cenestin dosage: Oral. During the same period patient was treated with CYCLOBENZAPRINE HCL (View Cyclobenzaprine Hcl Review and Cyclobenzaprine Hcl Label ), FLUTICASONE PROPIONATE (View Fluticasone Propionate Review and Fluticasone Propionate Label ).


5402776-3 | Adenocarcinoma Pancreas, Condition Aggravated, Oestrogen Receptor Assay Positive, Pancreatic Cyst, Progesterone Receptor Assay Positive
on Jul 19, 2007 Female patient from JAPAN , 50 years of age, was diagnosed with menopausal disorder and was treated with Cenestin (View Usage). Patient had the following side effects: adenocarcinoma pancreas, condition aggravated, oestrogen receptor assay positive, pancreatic cyst, progesterone receptor assay positive. Cenestin dosage: 0.625 Mg, Qd; Oral. Patient was hospitalized.

5379575-4 | Endometrial Cancer Metastatic, Lipid Metabolism Disorder, Metastases To Abdominal Cavity, Metastases To Liver, Metastases To Lymph Nodes
Patient was taking Cenestin (View Usage). After Cenestin was administered, patient had the following side effects: endometrial cancer metastatic, lipid metabolism disorder, metastases to abdominal cavity, metastases to liver, metastases to lymph nodes on May 21, 2007 from JAPAN Additional patient health information: Female patient , 40 years of age, was diagnosed with oestradiol decreased and. Cenestin dosage: 0.625 Mg. During the same period patient was treated with MEDROXYPROGESTERONE (View Medroxyprogesterone Review and Medroxyprogesterone Label ).

5348249-8 | Endometrial Cancer Metastatic, Lipid Metabolism Disorder, Metastases To Liver, Metastases To Lymph Nodes, Suprapubic Pain, Vaginal Haemorrhage
Adverse event was reported on May 21, 2007 by a Female patient taking Cenestin (View Usage) (Dosage: 0.625 Mg) was diagnosed with oestradiol decreased and. Location: JAPAN , 40 years of age, Patient experienced the following unwanted or unexpected effects: endometrial cancer metastatic, lipid metabolism disorder, metastases to liver, metastases to lymph nodes, suprapubic pain, vaginal haemorrhage. During the same period patient was treated with MEDROXYPROGESTERONE ACETATE (View Medroxyprogesterone Acetate Review and Medroxyprogesterone Acetate Label ).

5346900-X | Ovarian Cancer
on Sep 01, 2006 Female patient from UNITED STATES , 56 years of age, was treated with Cenestin (View Usage). Patient had the following side effects: ovarian cancer. Cenestin dosage: Oral. During the same period patient was treated with PREMARIN (Oral) (View Premarin Review and Premarin Label ), PREMPRO (Oral) (View Prempro Review and Prempro Label ), ESTRATEST (Oral) (View Estratest Review and Estratest Label ), ESTRACE (Oral) (View Estrace Review and Estrace Label ).

5346899-6 | Ovarian Cancer
on Aug 04, 2006 Female patient from UNITED STATES , 51 years of age, was treated with Cenestin (View Usage). After Cenestin was administered, patient had the following side effects: ovarian cancer. Cenestin dosage: Oral. During the same period patient was treated with PREMARIN (Oral) (View Premarin Review and Premarin Label ).

5346897-2 | Breast Cancer, Thrombosis
Patient was taking Cenestin (View Usage). Patient experienced the following unwanted or unexpected effects: breast cancer (What is breast cancer?), thrombosis on May 18, 2006 from UNITED STATES Additional patient health information: Female patient , 54 years of age, . Cenestin dosage: Oral. During the same period patient was treated with PREMARIN (Oral) (View Premarin Review and Premarin Label ), ESTRADERM (Oral) (View Estraderm Review and Estraderm Label ).

5337636-X | Feeling Cold, Lupus-like Syndrome
Adverse event was reported on May 10, 2007 by a Female patient taking Cenestin (View Usage) (Dosage: 1 Tablet, Qd, Oral) . Location: UNITED STATES , 54 years of age, Patient had the following side effects: feeling cold, lupus-like syndrome. During the same period patient was treated with INDAPAMIDE (View Indapamide Review and Indapamide Label ), TERAZOSIN HCL (View Terazosin Hcl Review and Terazosin Hcl Label ), CAPTOPRIL (View Captopril Review and Captopril Label ), ATORVASTATIN CALCIUM (View Atorvastatin Calcium Review and Atorvastatin Calcium Label ), NIACIN (View Niacin Review and Niacin Label ).

5022519-5 | Myocardial Infarction
on Aug 26, 2005 Female patient from UNITED STATES , 49 years of age, was diagnosed with menopausal symptoms and was treated with Cenestin (View Usage). After Cenestin was administered, patient had the following side effects: myocardial infarction. Cenestin dosage: 1 Tablet, Qd, Oral.

4657923-8 | Migraine
on Apr 29, 2004 Female patient from , 47 years of age, weighting 159.0 lb, was diagnosed with artificial menopause and was treated with Cenestin (View Usage). Patient experienced the following unwanted or unexpected effects: migraine (What is migraine?). Cenestin dosage: 0.90 Mg, Qd, Oral. During the same period patient was treated with . (View . Review and . Label ), LEVOXYL (View Levoxyl Review and Levoxyl Label ). Patient was hospitalized.

4657922-6 | Breast Cancer
Patient was taking Cenestin (View Usage). Patient had the following side effects: breast cancer (What is breast cancer?) on Mar 05, 2004 from Additional patient health information: Female patient , 63 years of age, . Cenestin dosage: . During the same period patient was treated with PROVERA (View Provera Review and Provera Label ), PREMPRO (MEDROXYPROGESTERONE ACETATE, ESROGENS CONJUGATED) (View Prempro (medroxyprogesterone Acetate, Esrogens Conjugated) Review and Prempro (medroxyprogesterone Acetate, Esrogens Conjugated) Label ), PREMARIN (View Premarin Review and Premarin Label ).

4657915-9 | Angina Pectoris, Anxiety, Blood Pressure Decreased, Dyspnoea, Hypersensitivity
Adverse event was reported on Mar 05, 2004 by a Female patient taking Cenestin (View Usage) (Dosage: 1.00 Tablet, Qd, Oral) was diagnosed with hot flush and. Location: , 43 years of age, weighting 194.9 lb, After Cenestin was administered, patient had the following side effects: angina pectoris, anxiety (What is anxiety?), blood pressure decreased, dyspnoea, hypersensitivity. During the same period patient was treated with PREVACID (View Prevacid Review and Prevacid Label ). Patient was hospitalized.